Effective April 23, 2021, CDC and FDA recommend that use of the Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine resume in the United States.

i

Up-to-Date Info : To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Effective April 23, 2021, CDC and FDA recommend that use of the Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine resume in the United States.

Supporting Files Public Domain

04/24/2021

File Language:

English

Details

Description:

Summary: The available data show that the vaccine’s known and potential benefits outweigh its known and potential risks.

Your answers to patient questions matter. Your strong recommendation can help them make an informed decision and feel confident about getting vaccinated against COVID-19.

CS324167 04/24/2021

More information: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html

talking-patients-jj-vaccine-html.pdf
Subjects:

Coronavirus Infections/prevention & Control COVID-19 Vaccines Patient Safety
Name as Subject:

Janssen COVID-19 vaccine
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:0c0f4b0e12a50c6277944efa74d593c4a9b6e11f97d2204c5564a39cc73abb32
Download URL:

https://stacks.cdc.gov/view/cdc/105542/cdc_105542_DS1.pdf
File Type:

[PDF - 157.79 KB ]

JJUpdate.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.